M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medicofarma Biotech SA
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Other Operating Expenses
-zł264.6k
CAGR 3-Years
35%
CAGR 5-Years
22%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Other Operating Expenses
-zł1.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-15%
R
Ryvu Therapeutics SA
WSE:RVU
Other Operating Expenses
zł23.1m
CAGR 3-Years
33%
CAGR 5-Years
-6%
CAGR 10-Years
8%
S
Selvita SA
WSE:SLV
Other Operating Expenses
-zł10.5m
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Other Operating Expenses?
Other Operating Expenses
-264.6k PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Other Operating Expenses amounts to -264.6k PLN.

What is Medicofarma Biotech SA's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
22%

Over the last year, the Other Operating Expenses growth was 25%. The average annual Other Operating Expenses growth rates for Medicofarma Biotech SA have been 35% over the past three years , 22% over the past five years .

Back to Top